Evidence map›Paper›PMID 30504832›Full record

ArticleScientific reports2018

Pretreatment with Total Flavonoid Extract from Dracocephalum Moldavica L. Attenuates Ischemia Reperfusion-induced Apoptosis.

Cheng Zeng, Wen Jiang, Xiaoyi Yang, Chenghui He, Wen Wang, Jianguo Xing

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. A Comprehensive Review of the Phenolic Compounds inMolecules (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Optimization of Liquid Fermentation ofMolecules (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Transformed Shoots ofMolecules (Basel, Switzerland) · 2020
    Article
  17. Article
  18. BioMed research international · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Cheng ZengCollege of Pharmacy, Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, China.
Wen JiangCollege of Pharmacy, Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, China.
Xiaoyi YangCollege of Pharmacy, Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, China.
Chenghui HeCollege of Pharmacy, Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, China.
Wen WangDepartment of Experimental Animal Center, Xuanwu Hospital of Capital Medical University, No. 45 Changchun Street, Beijing, China. lzwwang@163.com.
Jianguo XingCollege of Pharmacy, Xinjiang Medical University, No. 393 Xinyi Road, Urumqi, 830054, China. 442705861@qq.com.
Xinjiang Medical University · CNXinjiang Institute of Materia Medica · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously demonstrated the cardio-protection mediated by the total flavonoid extracted from Dracocephalum moldavica L. (TFDM) following myocardial ischemia reperfusion injury (MIRI). The present study assessed the presence and mechanism of TFDM-related cardio-protection on MIRI-induced apoptosis in vivo. Male Sprague-Dawley rats experienced 45-min ischemia with 12 h of reperfusion. Rats pretreated with TFDM (3, 10 or 30 mg/kg/day) were compared with Sham (no MIRI and no TFDM), MIRI (no TFDM), and Positive (trapidil tablets, 13.5 mg/kg/day) groups. In MIRI-treated rats, high dose-TFDM (H-TFDM) pre-treatment with apparently reduced release of LDH, CK-MB and MDA, enhanced the concentration of SOD in plasma, and greatly reduced the infarct size, apoptotic index and mitochondrial injury. H-TFDM pretreatment markedly promoted the phosphorylation of PI3K, Akt, GSK-3β and ERK1/2 in comparison with the MIRI model group. Western blot analysis after reperfusion also showed that H-TFDM decreased release of Bax, cleaved caspase-3, caspase-7 and caspase-9, and increased expression of Bcl-2 as evident by the higher Bcl-2/Bax ratio. TFDM cardio-protection was influenced by LY294002 (PI3K inhibitor) and PD98059 (ERK1/2 inhibitor). Taken together, these results provide convincing evidence of the benefit of TFDM pretreatment due to inhibited myocardial apoptosis as mediated by the PI3K/Akt/GSK-3β and ERK1/2 signaling pathways.

Indexed as

AnimalsApoptosisFlavonoidsLamiaceaeMalePlant ExtractsRatsReperfusion InjuryFlavonoidsPlant Extracts

Identifiers

PMID30504832
PMCPMC6269513
OpenAlexW2902481691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.